Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-05

Clinical Trial Update: Valacyclovir vs. Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected Persons [Phase 4]

View source ↗

Summary

Phase 4 trial comparing valacyclovir to acyclovir for suppression of herpes simplex virus type 2 in people co-infected with HIV-1, with measurement of effects o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACYCLOVIR (Acyclovir)
  • Valacyclovir (Valacyclovir)

Snippet

Sponsor: University of Washington | Conditions: HSV Infection, HIV Infection | Phase 4 | Status: COMPLETED | Results posted: 2014-03-05